Get started
Author

Naotaka Kumada

ORCID: 0009-0006-1993-5393
Observed ORCID: 0009-0006-1993-5393
OpenAlex ID: A5000824529
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients
2023 · Fumiya Sugino, Keita Nakane, et al. · Journal of Robotic Surgery · 8
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer
2023 · Fumiya Sugino, Keita Nakane, et al. · Life · 6
PDF
Efficacy and Safety of the “Trisection Method” Training System for Robot-Assisted Radical Cystectomy at a Single Institution in Japan
2022 · Keita Nakane, Toyohiro Yamada, et al. · Current Oncology · 5
PDF
[Metastatic Renal Cancer with Stevens-Johnson Syndrome after Nivolumab Treatment : A Case Report].
2022 · Naotaka Kumada, Hiroki Ito, et al. · PubMed · 2
Impact of Cytoreductive Nephrectomy in the Management of Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study
2024 · Naotaka Kumada, Koji Iinuma, et al. · Diseases · 1
Utility and safety of robot-assisted radical cystectomy in older patients with bladder cancer
2023 · Naotaka Kumada, Keita Nakane, et al. · Minimally Invasive Therapy & Allied Technologies · 1
A Rare Case of Bladder Metastasis From Endometrial Cancer Treated With Robot-Assisted Radical Cystectomy
2024 · Naotaka Kumada, Makoto Kawase, et al. · Cureus
PDF
Treatment Strategies for High-Risk Prostate Cancer - Utility of Combination Therapy of Neoadjuvant Therapy and Radical Prostatectomy to Improve Oncologic Outcomes
2023 · Keita Nakane, Makoto Kawase, et al. · Preprints.org
PDF
Works count: 8
Citation count: 23
H-index: 3
I10-index:
Year
Topic
Type